お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は皮膚がんの診断と治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは皮膚がんの診断と治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の皮膚がんの診断と治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは皮膚がんの診断と治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に皮膚がんの診断と治療市場を分類しています。本研究に含まれる主な企業は：Agilent、Amgen、Aqua Pharmaceuticals、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo、Elekta、Eli Lilly、Roche、GSK、iCAD、Bausch Health、Merck、Novartis、Pfizer、QIAGEN、Sanofi、Teva Pharmaceutical、Varian Medical Systems

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Actinic Keratoses (AK)
    Based cell carcinoma (BCC)
    Squamous cell carcinoma (SCC)
    Melanoma

用途別の市場セグメント：
    Hospitals
    Cancer research centers
    Clinics

本レポートの詳細内容
世界の皮膚がんの診断と治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、皮膚がんの診断と治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の皮膚がんの診断と治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の皮膚がんの診断と治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、皮膚がんの診断と治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

皮膚がんの診断と治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：皮膚がんの診断と治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：皮膚がんの診断と治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章皮膚がんの診断と治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：皮膚がんの診断と治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：皮膚がんの診断と治療の主要企業の概要を提供し、製品の説明と仕様、皮膚がんの診断と治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market
The global Skin Cancer Diagnosis and Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Skin Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Skin Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Skin Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Skin Cancer Diagnosis and Therapeutics include Agilent, Amgen, Aqua Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Elekta, Eli Lilly and Roche, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Skin Cancer Diagnosis and Therapeutics is widely used in various fields, such as Hospitals, Cancer research centers and Clinics,, etc. Hospitals provides greatest supports to the Skin Cancer Diagnosis and Therapeutics industry development. In 2023, global % revenue of Skin Cancer Diagnosis and Therapeutics went into Hospitals filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Skin Cancer Diagnosis and Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Skin Cancer Diagnosis and Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Skin Cancer Diagnosis and Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Skin Cancer Diagnosis and Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Skin Cancer Diagnosis and Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Skin Cancer Diagnosis and Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Agilent, Amgen, Aqua Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Elekta, Eli Lilly and Roche, etc.

Market Segmentation
By Company
    Agilent
    Amgen
    Aqua Pharmaceuticals
    AstraZeneca
    Bristol-Myers Squibb
    Daiichi Sankyo
    Elekta
    Eli Lilly
    Roche
    GSK
    iCAD
    Bausch Health
    Merck
    Novartis
    Pfizer
    QIAGEN
    Sanofi
    Teva Pharmaceutical
    Varian Medical Systems

Segment by Type
    Actinic Keratoses (AK)
    Based cell carcinoma (BCC)
    Squamous cell carcinoma (SCC)
    Melanoma

Segment by Application
    Hospitals
    Cancer research centers
    Clinics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Skin Cancer Diagnosis and Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Cancer Diagnosis and Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Skin Cancer Diagnosis and Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Actinic Keratoses (AK)
    Table 3. Key Players of Based cell carcinoma (BCC)
    Table 4. Key Players of Squamous cell carcinoma (SCC)
    Table 5. Key Players of Melanoma
    Table 6. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Skin Cancer Diagnosis and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Skin Cancer Diagnosis and Therapeutics Market Share by Region (2019-2024)
    Table 10. Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Skin Cancer Diagnosis and Therapeutics Market Share by Region (2025-2030)
    Table 12. Skin Cancer Diagnosis and Therapeutics Market Trends
    Table 13. Skin Cancer Diagnosis and Therapeutics Market Drivers
    Table 14. Skin Cancer Diagnosis and Therapeutics Market Challenges
    Table 15. Skin Cancer Diagnosis and Therapeutics Market Restraints
    Table 16. Global Skin Cancer Diagnosis and Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Skin Cancer Diagnosis and Therapeutics Revenue Share by Players (2019-2024)
    Table 18. Global Top Skin Cancer Diagnosis and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnosis and Therapeutics as of 2023)
    Table 19. Global Skin Cancer Diagnosis and Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Skin Cancer Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Skin Cancer Diagnosis and Therapeutics, Headquarters and Area Served
    Table 22. Global Key Players of Skin Cancer Diagnosis and Therapeutics, Product and Application
    Table 23. Global Key Players of Skin Cancer Diagnosis and Therapeutics, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Skin Cancer Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2019-2024)
    Table 27. Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2025-2030)
    Table 29. Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Skin Cancer Diagnosis and Therapeutics Revenue Share by Application (2019-2024)
    Table 31. Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Skin Cancer Diagnosis and Therapeutics Revenue Share by Application (2025-2030)
    Table 33. North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Skin Cancer Diagnosis and Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Skin Cancer Diagnosis and Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Skin Cancer Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Skin Cancer Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Skin Cancer Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Skin Cancer Diagnosis and Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Skin Cancer Diagnosis and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Skin Cancer Diagnosis and Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Agilent Company Details
    Table 66. Agilent Business Overview
    Table 67. Agilent Skin Cancer Diagnosis and Therapeutics Product
    Table 68. Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 69. Agilent Recent Developments
    Table 70. Amgen Company Details
    Table 71. Amgen Business Overview
    Table 72. Amgen Skin Cancer Diagnosis and Therapeutics Product
    Table 73. Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 74. Amgen Recent Developments
    Table 75. Aqua Pharmaceuticals Company Details
    Table 76. Aqua Pharmaceuticals Business Overview
    Table 77. Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Product
    Table 78. Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 79. Aqua Pharmaceuticals Recent Developments
    Table 80. AstraZeneca Company Details
    Table 81. AstraZeneca Business Overview
    Table 82. AstraZeneca Skin Cancer Diagnosis and Therapeutics Product
    Table 83. AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 84. AstraZeneca Recent Developments
    Table 85. Bristol-Myers Squibb Company Details
    Table 86. Bristol-Myers Squibb Business Overview
    Table 87. Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Product
    Table 88. Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 89. Bristol-Myers Squibb Recent Developments
    Table 90. Daiichi Sankyo Company Details
    Table 91. Daiichi Sankyo Business Overview
    Table 92. Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Product
    Table 93. Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 94. Daiichi Sankyo Recent Developments
    Table 95. Elekta Company Details
    Table 96. Elekta Business Overview
    Table 97. Elekta Skin Cancer Diagnosis and Therapeutics Product
    Table 98. Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 99. Elekta Recent Developments
    Table 100. Eli Lilly Company Details
    Table 101. Eli Lilly Business Overview
    Table 102. Eli Lilly Skin Cancer Diagnosis and Therapeutics Product
    Table 103. Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 104. Eli Lilly Recent Developments
    Table 105. Roche Company Details
    Table 106. Roche Business Overview
    Table 107. Roche Skin Cancer Diagnosis and Therapeutics Product
    Table 108. Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 109. Roche Recent Developments
    Table 110. GSK Company Details
    Table 111. GSK Business Overview
    Table 112. GSK Skin Cancer Diagnosis and Therapeutics Product
    Table 113. GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 114. GSK Recent Developments
    Table 115. iCAD Company Details
    Table 116. iCAD Business Overview
    Table 117. iCAD Skin Cancer Diagnosis and Therapeutics Product
    Table 118. iCAD Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 119. iCAD Recent Developments
    Table 120. Bausch Health Company Details
    Table 121. Bausch Health Business Overview
    Table 122. Bausch Health Skin Cancer Diagnosis and Therapeutics Product
    Table 123. Bausch Health Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 124. Bausch Health Recent Developments
    Table 125. Merck Company Details
    Table 126. Merck Business Overview
    Table 127. Merck Skin Cancer Diagnosis and Therapeutics Product
    Table 128. Merck Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 129. Merck Recent Developments
    Table 130. Novartis Company Details
    Table 131. Novartis Business Overview
    Table 132. Novartis Skin Cancer Diagnosis and Therapeutics Product
    Table 133. Novartis Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 134. Novartis Recent Developments
    Table 135. Pfizer Company Details
    Table 136. Pfizer Business Overview
    Table 137. Pfizer Skin Cancer Diagnosis and Therapeutics Product
    Table 138. Pfizer Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 139. Pfizer Recent Developments
    Table 140. QIAGEN Company Details
    Table 141. QIAGEN Business Overview
    Table 142. QIAGEN Skin Cancer Diagnosis and Therapeutics Product
    Table 143. QIAGEN Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 144. QIAGEN Recent Developments
    Table 145. Sanofi Company Details
    Table 146. Sanofi Business Overview
    Table 147. Sanofi Skin Cancer Diagnosis and Therapeutics Product
    Table 148. Sanofi Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 149. Sanofi Recent Developments
    Table 150. Teva Pharmaceutical Company Details
    Table 151. Teva Pharmaceutical Business Overview
    Table 152. Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Product
    Table 153. Teva Pharmaceutical Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 154. Teva Pharmaceutical Recent Developments
    Table 155. Varian Medical Systems Company Details
    Table 156. Varian Medical Systems Business Overview
    Table 157. Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Product
    Table 158. Varian Medical Systems Revenue in Skin Cancer Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 159. Varian Medical Systems Recent Developments
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Skin Cancer Diagnosis and Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Actinic Keratoses (AK) Features
    Figure 4. Based cell carcinoma (BCC) Features
    Figure 5. Squamous cell carcinoma (SCC) Features
    Figure 6. Melanoma Features
    Figure 7. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Skin Cancer Diagnosis and Therapeutics Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Cancer research centers Case Studies
    Figure 11. Clinics Case Studies
    Figure 12. Skin Cancer Diagnosis and Therapeutics Report Years Considered
    Figure 13. Global Skin Cancer Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Skin Cancer Diagnosis and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Skin Cancer Diagnosis and Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Skin Cancer Diagnosis and Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Skin Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnosis and Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Skin Cancer Diagnosis and Therapeutics Revenue in 2023
    Figure 19. North America Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2019-2030)
    Figure 21. North America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2019-2030)
    Figure 22. North America Skin Cancer Diagnosis and Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Skin Cancer Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Type (2019-2030)
    Figure 27. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Application (2019-2030)
    Figure 28. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Country (2019-2030)
    Figure 29. Germany Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Skin Cancer Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Skin Cancer Diagnosis and Therapeutics Market Share by Type (2019-2030)
    Figure 37. China Skin Cancer Diagnosis and Therapeutics Market Share by Application (2019-2030)
    Figure 38. Asia Skin Cancer Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Skin Cancer Diagnosis and Therapeutics Market Share by Type (2019-2030)
    Figure 40. Asia Skin Cancer Diagnosis and Therapeutics Market Share by Application (2019-2030)
    Figure 41. Asia Skin Cancer Diagnosis and Therapeutics Market Share by Region (2019-2030)
    Figure 42. Japan Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Skin Cancer Diagnosis and Therapeutics Market Share by Country (2019-2030)
    Figure 52. Brazil Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Agilent Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 59. Amgen Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 60. Aqua Pharmaceuticals Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 61. AstraZeneca Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 63. Daiichi Sankyo Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 64. Elekta Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 65. Eli Lilly Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 66. Roche Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 67. GSK Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 68. iCAD Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 69. Bausch Health Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 70. Merck Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 71. Novartis Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 72. Pfizer Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 73. QIAGEN Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 74. Sanofi Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 75. Teva Pharmaceutical Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 76. Varian Medical Systems Revenue Growth Rate in Skin Cancer Diagnosis and Therapeutics Business (2019-2024)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed